ARTICLE | Company News

Paratek, Serono SA deal

November 1, 2004 8:00 AM UTC

Paratek and SEO partnered to identify tetracycline derivatives from Paratek's library of non-antibiotic compounds to treat multiple sclerosis (MS). Paratek will perform medicinal chemistry and early preclinical testing. Once compounds have been shown to work in vivo they will be handed off to SEO for further preclinical testing. SEO is responsible for clinical development and worldwide marketing. ...